IMCR - Immunocore to present at upcoming investor conferences | Benzinga
Immunocore to present at upcoming investor conferences
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 01 September 2023) Immunocore Holdings Plc (NASDAQ:IMCR), a commercial-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infectious diseases and autoimmune conditions, today announced that management will present at the following investor conferences in September:
- Wells Fargo Healthcare Conference
Fireside Chat: Wednesday, September 6, 2023, at 11:00 a.m. EDT
- Citi 18th Annual BioPharma ...